The Cigna Group (NYSE:CI) Shares Bought by Fmr LLC

Fmr LLC boosted its stake in shares of The Cigna Group (NYSE:CI) by 2.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,230,397 shares of the health services provider’s stock after buying an additional 279,880 shares during the quarter. Fmr LLC owned 5.12% of The Cigna Group worth $4,929,978,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Dai ichi Life Insurance Company Ltd boosted its holdings in The Cigna Group by 35.6% during the 3rd quarter. Dai ichi Life Insurance Company Ltd now owns 65,940 shares of the health services provider’s stock valued at $22,844,000 after acquiring an additional 17,326 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of The Cigna Group by 6.7% during the third quarter. The Manufacturers Life Insurance Company now owns 729,252 shares of the health services provider’s stock worth $252,642,000 after purchasing an additional 45,891 shares in the last quarter. Qsemble Capital Management LP purchased a new position in shares of The Cigna Group in the third quarter valued at approximately $4,325,000. Private Trust Co. NA grew its holdings in shares of The Cigna Group by 3.1% in the third quarter. Private Trust Co. NA now owns 2,421 shares of the health services provider’s stock valued at $839,000 after purchasing an additional 73 shares in the last quarter. Finally, Loomis Sayles & Co. L P increased its stake in The Cigna Group by 21.2% during the 3rd quarter. Loomis Sayles & Co. L P now owns 246 shares of the health services provider’s stock worth $85,000 after buying an additional 43 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Stock Up 1.3 %

CI opened at $332.73 on Tuesday. The business has a 50 day moving average price of $334.74 and a two-hundred day moving average price of $338.63. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $370.83. The company has a market cap of $92.55 billion, a PE ratio of 31.39, a P/E/G ratio of 0.99 and a beta of 0.51. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. During the same quarter in the prior year, the business earned $6.77 earnings per share. The company’s quarterly revenue was up 29.8% compared to the same quarter last year. As a group, research analysts anticipate that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.68%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s payout ratio is 52.83%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on CI shares. Royal Bank of Canada decreased their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Jefferies Financial Group lifted their price objective on The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, September 17th. Finally, Stephens restated an “overweight” rating and set a $410.00 target price on shares of The Cigna Group in a research note on Friday, November 1st. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $394.64.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.